Literature DB >> 16221102

Presentation, prognosis and outcome of IgA nephropathy in Indian adults.

Bobby Chacko1, George T John, Nithya Neelakantan, Anila Korula, Narasimhan Balakrishnan, Meshach G Kirubakaran, Chakko K Jacob.   

Abstract

BACKGROUND: IgA nephropathy (IgAN) is not well characterized in India. This retrospective study of 478 patients with IgAN was performed to clarify the presenting features, prognostic factors and the renal survival rates of the disease.
METHODS: Three hundred and forty-seven patients who had been followed on average for 27 months after diagnosis were divided into two groups based on renal function at diagnosis. In group 1 (229 patients), the creatinine clearance estimated by the Modification of Diet in Renal Disease formula was <85 mL/min and in group 2 (118 patients) it was >/=85 mL/min.
RESULTS: The predominant modes of presentation were nephrotic syndrome, hypertension and renal failure. Twenty-nine percent of patients had more than a 20% decline in renal function at the last follow up. Multivariate analyses with stepwise logistic regression identified hypertension (odds ratio (OR) 3.5), nephrotic range proteinuria (OR 3.4) and sclerosed glomeruli on biopsy (OR 4.1) to be independently associated with progression in group 1 and hypertension (OR 2.3) in group 2. Seventeen percent of patients progressed to end-stage renal disease (ESRD). Using multivariate analysis by the Cox model, four risk factors for developing ESRD were identified: hypertension (hazard ratio (HR) 3.1); nephrotic proteinuria (HR 1.9); interstitial fibrosis (HR 2.5); and sclerosed glomeruli (HR 1.8). The renal survival rates at 1, 5 and 10 years were 84, 55 and 33%, respectively, with a median renal survival of 61 months from the time of biopsy.
CONCLUSION: The relatively rapid rate of progression of IgAN in India is suggestive towards a 'malignant' nature of the disease in this country.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16221102     DOI: 10.1111/j.1440-1797.2005.00445.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  12 in total

Review 1.  Autoimmune-mediated renal disease and hypertension.

Authors:  Erika I Boesen; Rahul M Kakalij
Journal:  Clin Sci (Lond)       Date:  2021-09-17       Impact factor: 6.876

2.  Clinico-Epidemiological Profile of Dialysis Services in Karnataka, India - A Multicentric Exploratory Study.

Authors:  Arvind Conjeevaram; Y J Anupama; Lloyd Vincent; Nandakumar B Sastry; Vishwanath Siddini; Manjunath Revanasiddappa; Sanjay Srinivasa; Anilkumar B Thimmegeowda; Manjunath J Kulkarni; Vivek S Patil
Journal:  Indian J Nephrol       Date:  2022-03-23

3.  Role of myofibroblasts and collagen type IV in patients of IgA nephropathy as markers of renal dysfunction.

Authors:  R W Minz; A Bakshi; S Chhabra; K Joshi; V Sakhuja
Journal:  Indian J Nephrol       Date:  2010-01

4.  Two consecutive recurrences of crescentic immunoglobulin A nephropathy in a renal transplant recipient.

Authors:  N Gopalakrishnan; S Murugananth; T Dineshkumar; J Dhanapriya; R Sakthirajan; T Balasubramaniyan
Journal:  Indian J Nephrol       Date:  2016-09

5.  Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.

Authors:  Soumita Bagchi; Raghavendra Lingaiah; Kalaivani Mani; Adarsh Barwad; Geetika Singh; Veena Balooni; Dipankar Bhowmik; Sanjay Kumar Agarwal
Journal:  PLoS One       Date:  2019-03-27       Impact factor: 3.240

6.  Low Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy--A Retrospective Registry-Based Cohort Study.

Authors:  Paschal Ruggajo; Einar Svarstad; Sabine Leh; Hans-Peter Marti; Anna Varberg Reisæther; Bjørn Egil Vikse
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

7.  Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort.

Authors:  Suceena Alexander; George T John; Anila Korula; T S Vijayakumar; Vinoi George David; Anjali Mohapatra; Anna T Valson; Shibu Jacob; Pradeep Mathew Koshy; Gautam Rajan; Elenjickal Elias John; Smita Mary Matthai; L Jeyaseelan; Babu Ponnusamy; Terence Cook; Charles Pusey; Mohamed R Daha; John Feehally; Jonathan Barratt; Santosh Varughese
Journal:  Wellcome Open Res       Date:  2018-07-26

8.  The precise long-term outcomes of adult IgA nephropathy by mail questionnaires: Better renal survival compared to earlier cohort studies.

Authors:  Eri Imai; Joichi Usui; Shuzo Kaneko; Tetsuya Kawamura; Machi Suka; Kunihiro Yamagata
Journal:  PLoS One       Date:  2020-05-15       Impact factor: 3.240

9.  Epidemiology, baseline characteristics and risk of progression in the first South-Asian prospective longitudinal observational IgA nephropathy cohort.

Authors:  Suceena Alexander; Santosh Varughese; Rajanbabu Franklin; Sanjeet Roy; Grace Rebekah; Vinoi George David; Anjali Mohapatra; Anna T Valson; Shibu Jacob; Pradeep Mathew Koshy; Gautham Rajan; Mohamed R Daha; John Feehally; Jonathan Barratt; George T John
Journal:  Kidney Int Rep       Date:  2020-12-07

10.  Supportive Management of IgA Nephropathy With Renin-Angiotensin Blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study.

Authors:  Soumita Bagchi; Kalaivani Mani; Anitha Swamy; Adarsh Barwad; Geetika Singh; Dipankar Bhowmik; Sanjay Kumar Agarwal
Journal:  Kidney Int Rep       Date:  2021-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.